date:Jun 23, 2014
e one of our technologies, Louis Judge III, director of technology transfer with the university, told Reuters Health.
Johnny Rodrigues, chief commercialization officer of Xemerge told Reuters Health theres still no timetable for when the hypoallergenic peanut products would be available to grocery stores or food manufacturers.
We have the FDA, and food manufacturers product cycles to factor in, Rodrigues added. Remember that in many cases, the peanut processors will be selling to a third party